In vitro consultation cancer screening and targeted anticancer drug research and development
Investors 3
Mentions in press and media 1
Date | Title | Description | Source |
06.10.2022 | BIOINFRA and 20/20 GeneSystems Announce U.S. Technology Lice... | Additional biomarkers and algorithm expected to improve diagnostic accuracy as interest in Multi-Can... | einpresswi... |